Advertisement
Canada markets closed

  • S&P/TSX

    22,308.93
    -66.90 (-0.30%)
     

  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     

  • DOW

    39,512.84
    +125.08 (+0.32%)
     

  • CAD/USD

    0.7317
    +0.0006 (+0.08%)
     

  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     

  • Bitcoin CAD

    83,227.66
    -2,472.34 (-2.88%)
     

  • CMC Crypto 200

    1,258.17
    -99.84 (-7.35%)
     

  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     

  • RUSSELL 2000

    2,059.78
    -13.85 (-0.67%)
     

  • 10-Yr Bond

    4.5040
    +0.0550 (+1.24%)
     

  • NASDAQ

    16,340.87
    -5.40 (-0.03%)
     

  • VOLATILITY

    12.55
    -0.14 (-1.10%)
     

  • FTSE

    8,433.76
    +52.41 (+0.63%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

  • CAD/EUR

    0.6789
    +0.0011 (+0.16%)
     
MARKETS LIVE BLOG:

STOCKS CLIMB AS DOW POSTS 8TH STRAIGHT WIN

Fed's Michelle Bowman echoes higher-for-longer mantra for interest rates

Five Star Equities Issues New Research Reports on CTIC, GEVO, SYUT and VJET

ACCESSWIRE

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at http://www.fivestarequities.com/ and get exclusive access to our numerous stock reports.

Cell Therapeutics Inc. (NASDAQ:CTIC - News) shares gained 6.86 percent to close at $1.87 a share Friday. The company and Baxter International Inc. have announced a worldwide licensing agreement to develop and commercialize pacritinib. Shares of Cell Therapeutics have gained approximately 44.0 percent year-to-date.

Get more information on Cell Therapeutics and free access to the in-depth equity report at:
www.FiveStarEquities.com/CTIC

Gevo, Inc. (NASDAQ:GEVO - News) shares surged 26.09 percent to close at $1.74 a share Friday. The stock traded between $1.38 and $2.18 on volume of 9.22 million shares traded. The company announced an agreement with The Coca-Cola Company to develop and commercialize 100% renewable plastic bottles. Shares of Gevo have gained approximately 13.0 percent year-to-date.

ADVERTISEMENT

Get more information on Gevo and free access to the in-depth equity report at:
www.FiveStarEquities.com/GEVO

Synutra International, Inc. (NASDAQ:SYUT - News) shares soared 36.54 percent to close at $9.79 a share Friday. The stock traded between $7.58 and $10.00 on volume 617,217 shares traded. The maker of infant formula will look to benefit from China’s announcement that it would ease its one child policy. Shares of Synutra International have gained approximately 110.0 percent year-to-date.

Get more information on Synutra International and free access to the in-depth equity report at:
www.FiveStarEquities.com/SYUT

Voxeljet AG (NYSE:VJET - News) shares spiked 12.58 percent to close at $58.99 a share Friday. The stock traded between $56.02 and $58.85 on volume 3.56 million shares traded. The company reported revenues for the third quarter of 2013 increased 77 percent year-over-year. Shares of Voxeljet have gained approximately 77.0 percent since its IPO.

Get more information on Voxeljet free access to the in-depth equity report at:
www.FiveStarEquities.com/VJET

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Five Star Equities
info@fivestarequities.com